Pasithea Therapeutics Stock Forward View - Accumulation Distribution
| KTTA Stock | USD 0.86 0 0.12% |
Pasithea Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Pasithea Therapeutics stock prices and determine the direction of Pasithea Therapeutics Corp's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pasithea Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Pasithea Therapeutics' share price is approaching 45. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Pasithea Therapeutics, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
Wall Street Target Price 3 | Quarterly Revenue Growth 14.981 |
Using Pasithea Therapeutics hype-based prediction, you can estimate the value of Pasithea Therapeutics Corp from the perspective of Pasithea Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Pasithea Relative Strength Index
Pasithea Therapeutics Hype to Price Pattern
Investor biases related to Pasithea Therapeutics' public news can be used to forecast risks associated with an investment in Pasithea. The trend in average sentiment can be used to explain how an investor holding Pasithea can time the market purely based on public headlines and social activities around Pasithea Therapeutics Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Pasithea Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Pasithea Therapeutics.
Pasithea Therapeutics after-hype prediction price | USD 0.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Pasithea Therapeutics to cross-verify your projections. Pasithea Therapeutics Additional Predictive Modules
Most predictive techniques to examine Pasithea price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pasithea using various technical indicators. When you analyze Pasithea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 8568.64 | 7364.38 |
| Check Pasithea Therapeutics Volatility | Backtest Pasithea Therapeutics | Information Ratio |
Pasithea Therapeutics Trading Date Momentum
| On January 30 2026 Pasithea Therapeutics Corp was traded for 0.86 at the closing time. The top price for the day was 0.89 and the lowest listed price was 0.84 . The trading volume for the day was 131.1 K. The trading history from January 30, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.12% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Pasithea Therapeutics to competition |
Other Forecasting Options for Pasithea Therapeutics
For every potential investor in Pasithea, whether a beginner or expert, Pasithea Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pasithea Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pasithea. Basic forecasting techniques help filter out the noise by identifying Pasithea Therapeutics' price trends.Pasithea Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pasithea Therapeutics stock to make a market-neutral strategy. Peer analysis of Pasithea Therapeutics could also be used in its relative valuation, which is a method of valuing Pasithea Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pasithea Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Pasithea Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pasithea Therapeutics shares will generate the highest return on investment. By undertsting and applying Pasithea Therapeutics stock market strength indicators, traders can identify Pasithea Therapeutics Corp entry and exit signals to maximize returns.
Pasithea Therapeutics Risk Indicators
The analysis of Pasithea Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pasithea Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pasithea stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.76 | |||
| Semi Deviation | 7.54 | |||
| Standard Deviation | 17.9 | |||
| Variance | 320.51 | |||
| Downside Variance | 88.97 | |||
| Semi Variance | 56.87 | |||
| Expected Short fall | (11.96) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Pasithea Therapeutics
The number of cover stories for Pasithea Therapeutics depends on current market conditions and Pasithea Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pasithea Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pasithea Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pasithea Therapeutics Short Properties
Pasithea Therapeutics' future price predictability will typically decrease when Pasithea Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pasithea Therapeutics Corp often depends not only on the future outlook of the potential Pasithea Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pasithea Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 6.9 M |
Check out Historical Fundamental Analysis of Pasithea Therapeutics to cross-verify your projections. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pasithea Therapeutics. Expected growth trajectory for Pasithea significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pasithea Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.43) | Revenue Per Share | Quarterly Revenue Growth 14.981 | Return On Assets | Return On Equity |
The market value of Pasithea Therapeutics is measured differently than its book value, which is the value of Pasithea that is recorded on the company's balance sheet. Investors also form their own opinion of Pasithea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pasithea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pasithea Therapeutics' market value can be influenced by many factors that don't directly affect Pasithea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Pasithea Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Pasithea Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Pasithea Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.